Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.

OBJECTIVE: To evaluate the safety and efficacy of recombinant gamma interferon (rIFN gamma) in the treatment of patients with systemic sclerosis. METHODS: Sixteen patients with systemic sclerosis were treated with r-IFN gamma, 60 micrograms m-2 (low dose, n = 10) and 150 micrograms m-2 (high dose, n...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vlachoyiannopoulos, P G, Tsifetaki, N, Dimitriou, I, Galaris, D, Papiris, S A, Moutsopoulos, H M
Médium: Artigo
Jazyk:Inglês
Vydáno: 1996
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1010296/
https://ncbi.nlm.nih.gov/pubmed/8984943
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky